PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Infectious Diseases Section, Hospital de Galdakao-Usansolo, Galdakao, Vizcaya, Spain.\', \'Infectious Diseases Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.\', \'Intensive Care Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain.\', \'Internal Medicine Service, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.\', \'Infectious Diseases Section, Hospital Universitari Son Espases, Palma de Mallorca, Spain.\', \'Internal Medicine Service, Hospital 12 de Octubre, Madrid, Spain.\', \'Infectious Diseases Section, Hospital Universitario La Princesa, Madrid, Spain.\', \'Internal Medicine Service, Hospital Universitario y Politécnico La Fe, Valencia, Spain.\', \'Internal Medicine Service, Hospital Son Llàtzer, Palma de Mallorca, Spain.\', \'Internal Medicine Service, Hospital Regional Universitario, Málaga, Spain.\', \'Internal Medicine Service, Hospital Universitario Dr Peset, Valencia, Spain.\', \'Internal Medicine Service, Hospital General Universitario, Alicante, Spain.\', \'Infectious Diseases Unit, Hospital Clínico Universitario, Valladolid, Spain.\', \'Internal Medicine Service, Hospital POVISA, Pontevedra, Spain.\', \'Infectious Diseases Unit, Hospital Universitario Central de Asturias, Oviedo, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1371/journal.pone.0262777
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 35085321
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
?:title
  • Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients hospitalized with COVID-19.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all